LeMaitre Vascular, Inc. (LMAT)
USD 90.34
(-0.65%)
USD 90.34
(-0.65%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 193.48 Million USD | 19.69% |
| 2022 | 161.65 Million USD | 4.68% |
| 2021 | 154.42 Million USD | 19.37% |
| 2020 | 129.36 Million USD | 10.35% |
| 2019 | 117.23 Million USD | 11.05% |
| 2018 | 105.56 Million USD | 4.66% |
| 2017 | 100.86 Million USD | 13.14% |
| 2016 | 89.15 Million USD | 13.78% |
| 2015 | 78.35 Million USD | 10.2% |
| 2014 | 71.09 Million USD | 10.14% |
| 2013 | 64.54 Million USD | 13.77% |
| 2012 | 56.73 Million USD | -1.65% |
| 2011 | 57.68 Million USD | 2.9% |
| 2010 | 56.06 Million USD | 10.12% |
| 2009 | 50.9 Million USD | 4.49% |
| 2008 | 48.72 Million USD | 17.55% |
| 2007 | 41.44 Million USD | 19.69% |
| 2006 | 34.62 Million USD | 12.7% |
| 2005 | 30.72 Million USD | 17.35% |
| 2004 | 26.18 Million USD | 26.71% |
| 2003 | 20.66 Million USD | 19.0% |
| 2002 | 17.36 Million USD | 38.36% |
| 2001 | 12.55 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 54.81 Million USD | -1.84% |
| 2024 Q2 | 55.84 Million USD | 4.43% |
| 2024 Q1 | 53.47 Million USD | 9.4% |
| 2023 FY | 193.48 Million USD | 19.69% |
| 2023 Q1 | 47.07 Million USD | 14.95% |
| 2023 Q2 | 50.11 Million USD | 6.46% |
| 2023 Q3 | 47.41 Million USD | -5.4% |
| 2023 Q4 | 48.88 Million USD | 3.1% |
| 2022 FY | 161.65 Million USD | 4.68% |
| 2022 Q2 | 42.1 Million USD | 6.44% |
| 2022 Q1 | 39.56 Million USD | 0.15% |
| 2022 Q4 | 40.95 Million USD | 4.93% |
| 2022 Q3 | 39.02 Million USD | -7.31% |
| 2021 Q2 | 40.67 Million USD | 13.34% |
| 2021 Q3 | 38.36 Million USD | -5.66% |
| 2021 FY | 154.42 Million USD | 19.37% |
| 2021 Q4 | 39.5 Million USD | 2.96% |
| 2021 Q1 | 35.88 Million USD | -4.43% |
| 2020 Q3 | 36.41 Million USD | 46.54% |
| 2020 FY | 129.36 Million USD | 10.35% |
| 2020 Q4 | 37.54 Million USD | 3.11% |
| 2020 Q1 | 30.55 Million USD | 1.26% |
| 2020 Q2 | 24.85 Million USD | -18.66% |
| 2019 Q1 | 28.47 Million USD | 0.32% |
| 2019 Q3 | 29.1 Million USD | -1.3% |
| 2019 Q4 | 30.17 Million USD | 3.68% |
| 2019 FY | 117.23 Million USD | 11.05% |
| 2019 Q2 | 29.48 Million USD | 3.53% |
| 2018 Q3 | 24.16 Million USD | -10.57% |
| 2018 Q1 | 25.99 Million USD | -0.61% |
| 2018 FY | 105.56 Million USD | 4.66% |
| 2018 Q4 | 28.38 Million USD | 17.48% |
| 2018 Q2 | 27.02 Million USD | 3.95% |
| 2017 FY | 100.86 Million USD | 13.14% |
| 2017 Q4 | 26.15 Million USD | 5.36% |
| 2017 Q3 | 24.82 Million USD | -3.62% |
| 2017 Q2 | 25.75 Million USD | 6.69% |
| 2017 Q1 | 24.13 Million USD | 3.65% |
| 2016 FY | 89.15 Million USD | 13.78% |
| 2016 Q3 | 23.21 Million USD | 3.69% |
| 2016 Q2 | 22.38 Million USD | 10.52% |
| 2016 Q4 | 23.28 Million USD | 0.31% |
| 2016 Q1 | 20.25 Million USD | -1.1% |
| 2015 Q4 | 20.48 Million USD | 7.66% |
| 2015 FY | 78.35 Million USD | 10.2% |
| 2015 Q3 | 19.02 Million USD | -4.38% |
| 2015 Q2 | 19.89 Million USD | 5.01% |
| 2015 Q1 | 18.94 Million USD | 1.42% |
| 2014 Q3 | 17.5 Million USD | -3.63% |
| 2014 Q4 | 18.68 Million USD | 6.74% |
| 2014 FY | 71.09 Million USD | 10.14% |
| 2014 Q1 | 16.75 Million USD | -6.49% |
| 2014 Q2 | 18.16 Million USD | 8.4% |
| 2013 Q3 | 15.3 Million USD | -4.08% |
| 2013 Q4 | 17.91 Million USD | 17.1% |
| 2013 Q1 | 15.38 Million USD | 3.93% |
| 2013 FY | 64.54 Million USD | 13.77% |
| 2013 Q2 | 15.95 Million USD | 3.7% |
| 2012 Q3 | 13.64 Million USD | -4.99% |
| 2012 Q4 | 14.8 Million USD | 8.47% |
| 2012 Q2 | 14.36 Million USD | 3.11% |
| 2012 Q1 | 13.92 Million USD | 3.86% |
| 2012 FY | 56.73 Million USD | -1.65% |
| 2011 FY | 57.68 Million USD | 2.9% |
| 2011 Q1 | 14.59 Million USD | 1.16% |
| 2011 Q2 | 15.11 Million USD | 3.52% |
| 2011 Q3 | 14.56 Million USD | -3.63% |
| 2011 Q4 | 13.41 Million USD | -7.92% |
| 2010 Q3 | 13.65 Million USD | -3.55% |
| 2010 Q4 | 14.43 Million USD | 5.68% |
| 2010 FY | 56.06 Million USD | 10.12% |
| 2010 Q1 | 13.81 Million USD | 1.7% |
| 2010 Q2 | 14.15 Million USD | 2.48% |
| 2009 Q2 | 12.63 Million USD | 11.3% |
| 2009 Q1 | 11.34 Million USD | -6.3% |
| 2009 FY | 50.9 Million USD | 4.49% |
| 2009 Q4 | 13.58 Million USD | 1.78% |
| 2009 Q3 | 13.34 Million USD | 5.67% |
| 2008 FY | 48.72 Million USD | 17.55% |
| 2008 Q2 | 12.73 Million USD | 7.53% |
| 2008 Q3 | 12.02 Million USD | -5.62% |
| 2008 Q4 | 12.11 Million USD | 0.73% |
| 2008 Q1 | 11.84 Million USD | 6.69% |
| 2007 FY | 41.44 Million USD | 19.69% |
| 2007 Q4 | 11.1 Million USD | 9.46% |
| 2007 Q2 | 10.31 Million USD | 4.37% |
| 2007 Q3 | 10.14 Million USD | -1.66% |
| 2007 Q1 | 9.88 Million USD | 12.86% |
| 2006 Q1 | 8.57 Million USD | 8.82% |
| 2006 Q4 | 8.75 Million USD | 2.54% |
| 2006 FY | 34.62 Million USD | 12.7% |
| 2006 Q3 | 8.54 Million USD | -2.51% |
| 2006 Q2 | 8.76 Million USD | 2.21% |
| 2005 Q3 | 7.82 Million USD | 3.85% |
| 2005 Q4 | 7.87 Million USD | 0.72% |
| 2005 Q2 | 7.53 Million USD | 0.39% |
| 2005 FY | 30.72 Million USD | 17.35% |
| 2005 Q1 | 7.5 Million USD | 14.61% |
| 2004 FY | 26.18 Million USD | 26.71% |
| 2004 Q4 | 6.54 Million USD | -0.02% |
| 2004 Q1 | 6.54 Million USD | 0.0% |
| 2004 Q3 | 6.54 Million USD | 0.0% |
| 2004 Q2 | 6.54 Million USD | 0.0% |
| 2003 FY | 20.66 Million USD | 19.0% |
| 2002 FY | 17.36 Million USD | 38.36% |
| 2001 FY | 12.55 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | -100.226% |
| AngioDynamics, Inc. | 303.91 Million USD | 36.336% |
| AtriCure, Inc. | 399.24 Million USD | 51.538% |
| Avinger, Inc. | 7.65 Million USD | -2428.542% |
| Azenta, Inc. | 665.07 Million USD | 70.908% |
| BioLife Solutions, Inc. | 143.27 Million USD | -35.048% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 94.615% |
| Daxor Corporation | 1.28 Million USD | -15009.858% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -958.504% |
| Femasys Inc. | 1.07 Million USD | -17949.386% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | -72.369% |
| Hologic, Inc. | 4.03 Billion USD | 95.199% |
| ICU Medical, Inc. | 2.25 Billion USD | 91.435% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 97.284% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -578.471% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -16688.505% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -16688.505% |
| Masimo Corporation | 2.04 Billion USD | 90.553% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | -99.265% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 84.612% |
| Nephros, Inc. | 14.23 Million USD | -1258.927% |
| NovoCure Limited | 509.33 Million USD | 62.013% |
| NEXGEL, Inc. | 4.08 Million USD | -4631.817% |
| NEXGEL, Inc. | 4.08 Million USD | -4631.817% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -6546.651% |
| OraSure Technologies, Inc. | 405.47 Million USD | 52.282% |
| Pro-Dex, Inc. | 53.84 Million USD | -259.342% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -10769.32% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -912.775% |
| QuidelOrtho Corporation | 2.99 Billion USD | 93.546% |
| Repligen Corporation | 638.76 Million USD | 69.71% |
| Sanara MedTech Inc. | 64.98 Million USD | -197.714% |
| STAAR Surgical Company | 322.41 Million USD | 39.989% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -285.242% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 95.12% |
| Jin Medical International Ltd. | 19.82 Million USD | -876.134% |